A wide variety of healthcare-related research is performed at the LCN, from biosensing to imaging, diagnostics and therapeutics.
|
|
High-speed, ultra low volume protein denaturation: Microfluidics and fluorescence spectroscopy is combined in a novel nanolitre assay for drug discovery, diagnostics and pathogen detection. |
 |
Label-free technology for drug-target interactions: Arrays of diving-board-shaped cantilevers are used to detect small molecule drugs, proteins, virus particles and bacterial cells. Read our press release on role of cantilevers in tackling hospital superbugs. |
|
|
Cancer cell detection from LCN spin-out Endomagnetics: The SentiMag, a magnetic detecting device for use in breast cancer, has been developed to allow specialists to monitor the spread of cancer cells more easily. Recent news on the Endomagnetics spin-out can be read here. |
